This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations.

When it comes to dividend investing, there are two basic paths you can take. You could seek out businesses that are raising ...

AbbVie will write off $3.5 billion related to its $8.7 billion investment in Cerevel Therapeutics following the failure of the company's key schizophrenia drug, emraclidine, The Wall Street ...

Discover how to navigate inflation with long-term investments in resilient companies like Coca-Cola, AbbVie, and TC Energy.

Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some ...

It's encouraging to see that AbbVie has been growing its earnings per share at 5.7% a year over the past five years. While EPS is growing at a decent rate, but future growth could be limited by ...

Medtronic has been raising its dividend for 47 consecutive years and it offers a high yield now. Bristol Myers Squibb offers ...

In its latest attempt to bulk up its cancer drug portfolio, AbbVie has signed a new licensing agreement with China-based Simcere Zaiming to develop a treatment for myeloma, a type of blood cancer ...

AbbVie has made another bolt-on deal in the immunology ... in solid tumours and address treatment resistance. One lab study of OSE-230 published in the Frontiers in Immunology journal last year ...